Author Correction: Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity

被引：0
|
作者：
Chun Jing Wang
Lina Petersone
Natalie M. Edner
Frank Heuts
Vitalijs Ovcinnikovs
Elisavet Ntavli
Alexandros Kogimtzis
Astrid Fabri
Yassin Elfaki
Luke P. Houghton
Ralf J. Hosse
David A. Schubert
Andreas P. Frei
Ellen M. Ross
Lucy S. K. Walker
机构：
[1] University College London Division of Infection & Immunity,Institute of Immunity & Transplantation, Pears Building
[2] Roche Pharma Research & Early Development (pRED),Roche Innovation Center Zurich
[3] Roche Pharma Research & Early Development (pRED),Roche Innovation Center Basel
来源：
Nature Communications | / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor
    Hirai, Toshihito
    Lin, Po-Yu
    Ramos, Teresa L.
    Simonetta, Federico
    Su, Leon L.
    Picton, Lora K.
    Baker, Jeanette
    Lohmeyer, Juliane K.
    Garcia, K. Christopher
    Negrin, Robert S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (12) : 3061 - 3068
  • [42] IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors
    Whitehouse, Gavin
    Gray, Elizabeth
    Mastoridis, Sotiris
    Merritt, Elliot
    Kodela, Elisavet
    Yang, Jennie H. M.
    Danger, Richard
    Mairal, Marta
    Christakoudi, Sofia
    Lozano, Juan J.
    Macdougall, Iain C.
    Tree, Timothy I. M.
    Sanchez-Fueyo, Alberto
    Martinez-Llordella, Marc
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (27) : 7083 - 7088
  • [43] INTERLEUKIN-10 INHIBITS HUMAN T-CELL PROLIFERATION AND IL-2 PRODUCTION
    TAGA, K
    TOSATO, G
    FASEB JOURNAL, 1992, 6 (04): : A1333 - A1333
  • [44] Low-dose IL-2 therapy expands human regulatory T cell populations
    Nature Reviews Immunology, 2012, 12 (1) : 6 - 6
  • [45] Chimeric cytokine receptor provides IL-2 signaling for engineered regulatory T cell therapy
    Cortez, Jessica T.
    Ly, Han
    Trotta, Eleonora
    Matthaei, James F.
    Kegler, Peter
    Phong, Brian
    Fiebiger, Benjamin M.
    Torres, Josue
    Chase, Jack
    Mileur, Trevor
    Beilke, Joshua N.
    Bluestone, Jeffrey A.
    Ramsdell, Fred
    McKenzie, Brent S.
    Van Gool, Frederic
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [46] TRAF3 restrains regulatory T cell development by modulating IL-2 signaling
    Yi, Zuoan
    Lin, Waiwai
    Stunz, Laura
    Bishop, Gail
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [47] Dynamic changes in the regulatory T-cell heterogeneity and function by murine IL-2 mutein
    Lu, Daniel R.
    Wu, Hao
    Driver, Ian
    Ingersoll, Sarah
    Sohn, Sue
    Wang, Songli
    Li, Chi-Ming
    Phee, Hyewon
    LIFE SCIENCE ALLIANCE, 2020, 3 (05)
  • [48] KERATINOCYTE-DERIVED T-CELL COSTIMULATION INDUCES PREFERENTIAL PRODUCTION OF IL-2 AND IL-4 BUT NOT IFN-GAMMA
    GOODMAN, RE
    NESTLE, F
    NAIDU, YM
    GREEN, JM
    THOMPSON, CB
    NICKOLOFF, BJ
    TURKA, LA
    JOURNAL OF IMMUNOLOGY, 1994, 152 (11): : 5189 - 5198
  • [49] CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice:: implications for the nonredundant function of IL-2
    Malek, TR
    Yu, AX
    Vincek, V
    Scibelli, P
    Kong, L
    IMMUNITY, 2002, 17 (02) : 167 - 178
  • [50] Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans
    Mitchell, Duane A.
    Cui, Xiuyu
    Schmittling, Robert J.
    Sanchez-Perez, Luis
    Snyder, David J.
    Congdon, Kendra L.
    Archer, Gary E.
    Desjardins, Annick
    Friedman, Allan H.
    Friedman, Henry S.
    Herndon, James E., II
    McLendon, Roger E.
    Reardon, David A.
    Vredenburgh, James J.
    Bigner, Darell D.
    Sampson, John H.
    BLOOD, 2011, 118 (11) : 3003 - 3012
12345